...
首页> 外文期刊>Drugs of today: Medicamentos de actualidad >Evidence Europe 2017 London, UK - February 22-23, 2017
【24h】

Evidence Europe 2017 London, UK - February 22-23, 2017

机译:2017年欧洲证据展,英国伦敦,2017年2月22-23日

获取原文
获取原文并翻译 | 示例
           

摘要

As the political backdrop changes in both the U.S. and Europe, volatility in the pharma industry is beginning to be felt as the sector becomes sensitive to the uncertainty. U.S. President Trump has stated he will pursue an agenda against high U.S. drug prices and is expected to seek to repeal the Affordable Care Act, while in Europe, Brexit casts further unknowns in regulatory authorization procedures, trade and external reference pricing. With these factors in mind, Terrapin 's Evidence Europe meeting provided for a very topical discussion on the use of evidence to define and communicate value in healthcare. With a particular focus on real-world evidence, the conference used presentations, panel briefings and roundtable discussions to foster debate on the challenges faced by industry as it negotiates the current fragile environment.
机译:随着美国和欧洲政治背景的变化,随着制药行业对不确定性变得敏感,制药行业的波动性开始显现。美国总统特朗普表示,他将推行一项反对美国高药品价格的议程,并预计将寻求废除《平价医疗法案》,而在欧洲,英国脱欧在监管授权程序、贸易和外部参考定价方面带来了进一步的未知数。考虑到这些因素,Terrapin 的 Evidence Europe 会议就使用证据来定义和传达医疗保健的价值进行了非常热门的讨论。会议特别关注真实世界的证据,通过演讲、小组简报和圆桌讨论来促进对行业在谈判当前脆弱环境时所面临的挑战的辩论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号